Energy metabolism in adenosine deaminase-inhibited human erythrocytes
- PMID: 3486057
- DOI: 10.1016/0009-8981(86)90179-8
Energy metabolism in adenosine deaminase-inhibited human erythrocytes
Abstract
The metabolic changes induced by the deoxycoformycin inhibition of adenosine deaminase were studied in human erythrocytes incubated with nucleosides. 1 Adenosine nucleotide levels and glycolytic rate were increased by adenosine. 2 With deoxyadenosine, the cellular ATP level was reduced when dATP increased and the glycolytic rate was similarly enhanced. 3 The hypoxanthine production was equivalent in both cases. Our data demonstrate that human red cells are able to catabolize adenine deoxynucleotides into hypoxanthine, and the control of energy metabolism is not impaired by adenosine deaminase inhibition when PO identical to 4 and NAD+ are not limiting.
Similar articles
-
Mechanism of adenosine triphosphate catabolism induced by deoxyadenosine and by nucleoside analogues in adenosine deaminase-inhibited human erythrocytes.Cancer Res. 1989 Sep 15;49(18):4983-9. Cancer Res. 1989. PMID: 2788493
-
Deoxyadenosine triphosphate accumulation in erythrocytes of deoxycoformycin-treated mice.Biochem Pharmacol. 1982 Apr 15;31(8):1545-51. doi: 10.1016/0006-2952(82)90379-3. Biochem Pharmacol. 1982. PMID: 6980005
-
ATP depletion as a consequence of adenosine deaminase inhibition in man.Proc Natl Acad Sci U S A. 1980 Oct;77(10):6157-61. doi: 10.1073/pnas.77.10.6157. Proc Natl Acad Sci U S A. 1980. PMID: 6969403 Free PMC article.
-
Inhibitors of adenosine deaminase.Pharmacol Ther. 1982;17(3):399-429. doi: 10.1016/0163-7258(82)90023-7. Pharmacol Ther. 1982. PMID: 6187032 Review. No abstract available.
-
Adenosine deaminase inhibitors: their role in chemotherapy and immunosuppression.Cancer Chemother Pharmacol. 1980;4(4):227-35. doi: 10.1007/BF00255266. Cancer Chemother Pharmacol. 1980. PMID: 7002342 Review. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials